Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Northcott

Showing results (141-150 of 223) with videos related to

Pageof 23
Sort By:
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.
Acta Neuropathologica|December 14, 2011
Biological and clinical heterogeneity of MYCN-amplified medulloblastomaAndrey Korshunov, Marc Remke, Marcel Kool, et al.
Nature Genetics|June 14, 2022
Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programsMalgorzata Gozdecka, Eshwar Meduri, Milena Mazan, et al.
Nature Genetics|May 9, 2018
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programsMalgorzata Gozdecka, Eshwar Meduri, Milena Mazan, et al.
Genes & Development|May 19, 2010
Pleiotropic role for MYCN in medulloblastomaFredrik J Swartling, Matthew R Grimmer, Christopher S Hackett, et al.
Cancer Cell|March 14, 2018
NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in MedulloblastomaAlexandra Garancher, Charles Y Lin, Morgane Morabito, et al.
Cell Reports. Medicine|June 25, 2025
Targeting synthetic lethality between non-homologous end joining and radiation in very-high-risk medulloblastomaAlexandria DeCarlo, Graham MacLeod, Carolina Fernandes da Silva, et al.
Nature Communications|March 21, 2017
Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programmeWeijun Feng, Daisuke Kawauchi, Huiqin Körkel-Qu, et al.
Pageof 23

Showing results (141-150 of 223) with videos related to

Sort By:
Pageof 23
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.
Acta Neuropathologica|December 14, 2011
Biological and clinical heterogeneity of MYCN-amplified medulloblastomaAndrey Korshunov, Marc Remke, Marcel Kool, et al.
Nature Genetics|June 14, 2022
Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programsMalgorzata Gozdecka, Eshwar Meduri, Milena Mazan, et al.
Nature Genetics|May 9, 2018
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programsMalgorzata Gozdecka, Eshwar Meduri, Milena Mazan, et al.
Genes & Development|May 19, 2010
Pleiotropic role for MYCN in medulloblastomaFredrik J Swartling, Matthew R Grimmer, Christopher S Hackett, et al.
Cancer Cell|March 14, 2018
NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in MedulloblastomaAlexandra Garancher, Charles Y Lin, Morgane Morabito, et al.
Cell Reports. Medicine|June 25, 2025
Targeting synthetic lethality between non-homologous end joining and radiation in very-high-risk medulloblastomaAlexandria DeCarlo, Graham MacLeod, Carolina Fernandes da Silva, et al.
Nature Communications|March 21, 2017
Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programmeWeijun Feng, Daisuke Kawauchi, Huiqin Körkel-Qu, et al.
Pageof 23